首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1528934

高效能液相層析市場 - 按產品類型（儀器、消耗品和配件）、按應用（臨床研究應用、診斷應用、法醫應用）、最終用途和預測，2024 年 - 2032 年

High Performance Liquid Chromatography Market - By Product Type (Instruments, Consumables & Accessories), By Application (Clinical Research Applications, Diagnostic Applications, Forensic Applications), End-use & Forecast, 2024 - 2032

出版日期: 2024年05月07日 | 出版商:

Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於製藥和生物技術研究中對精確、高效分析技術的需求不斷成長，高性能液相層析市場規模在 2024 年至 2032 年間將實現 5.3% 的複合年成長率。慢性病的增加以及隨之而來的對新藥發現的需求正在推動製藥業對先進 HPLC（高效液相層析）系統的需求。據報道，大約三分之一的成年人患有多種慢性病。

世界各地的監管機構也在對環境和食品中的污染物和污染物水平執行嚴格的指導方針，進一步需要可靠和靈敏的分析方法。檢測微量污染物和摻假物的能力也使液相層析成為遵守這些法規不可或缺的工具。 HPLC 技術的不斷進步，包括超高效液相層析 (UHPLC) 系統的開發和檢測方法的改進，將進一步推動市場成長。

整個產業分為產品類型、應用、最終用戶和地區。

消耗品和配件產品類型領域的 HPLC 市場預計到 2032 年將實現強勁成長，因為它們在支援連續運作和效率方面發揮著重要作用。色譜管柱、過濾器、樣品瓶和溶劑等消耗品是分析中樣品製備、分離和檢測過程所需的關鍵組件。固定相等消耗品技術的進步也提高了色譜性能、靈敏度和重現性，進一步推動了該細分市場的成長。

就最終用途而言，由於在臨床診斷和研究中發揮至關重要的作用，臨床實驗室領域的高性能液相層析市場預計在 2024 年至 2032 年期間將出現大幅複合年成長率。 HPLC 廣泛應用於臨床實驗室，以高靈敏度和精確度分析生物標記、藥物化合物、維生素、荷爾蒙和代謝物。它還使醫療保健專業人員能夠有效地診斷疾病、監測治療藥物水平並進行藥物動力學研究。

亞太地區高效液相層析產業將在2024年至2032年間實現強勁成長。這些國家也越來越關注藥品生產中的藥物發現、品質控制和監管合規性，刺激了區域市場的成長。

產業生態系統分析
產業影響力
- 成長動力
  - 分析結果準確度高
  - HPLC 技術的進步
  - HPLC 測試在藥物核准中的重要性日益增加
  - 研發支出增加
- 產業陷阱與挑戰
  - 缺乏熟練的專業人員
  - HPLC 系統成本高
成長潛力分析
監管環境
技術景觀
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品類型，2021 - 2032 年

主要趨勢
儀器儀表
- 高效液相層析系統
- 泵浦
- 偵測器
- 其他儀器
耗材及配件
- 專欄
  - 反相 HPLC 柱
  - 正相 HPLC 柱
  - 離子交換高效液相層析管柱
  - 其他高效液相層析管柱
- 過濾器
- 小瓶
- 管
- 其他耗材及配件

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
臨床研究應用
診斷應用
法醫應用
其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
製藥和生物技術公司
臨床實驗室
學術研究機構
其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Gilson Incorporated
Hamilton Company
Hitachi High-Tech Corporation
Merck KGaA
Mitsubishi Chemical Group Corporation
PerkinElmer Inc.
Shimadzu Corporation
Thermo Fisher Scientific
Tosoh Corporation
Waters

簡介目錄

Product Code: 9385

High-performance liquid chromatography market size will register a 5.3% CAGR between 2024 and 2032 driven by increasing demand for precise and efficient analytical techniques in pharmaceutical and biotechnological research. The rise in chronic diseases and the consequent need for novel drug discoveries is propelling the demand for advanced HPLC (high performance liquid chromatography) systems in the pharmaceutical industry. As per reports, around one-third of all adults experienced multiple chronic conditions.

Regulatory bodies worldwide are also enforcing stringent guidelines for contaminant and pollutant levels in the environment and food products, further necessitating reliable and sensitive analytical methods. The capability to detect trace amounts of contaminants and adulterants also makes liquid chromatography an indispensable tool for compliance with these regulations. The continuous advancements in HPLC technology, including the development of ultra-high-performance liquid chromatography (UHPLC) systems and improved detection methods will further drive the market growth.

The overall industry is divided into product type, application, end-user, and region.

HPLC market from the consumables & accessories product type segment is slated to record strong growth through 2032 due to their essential role in supporting continuous operation and efficiency. Consumables, such as columns, filters, vials, and solvents are critical components required for sample preparation, separation, and detection processes in analysis. Advancements in consumable technologies, such as stationary phases are also enhancing the chromatographic performance, sensitivity, and reproducibility, further driving the segment growth.

With respect to end-use, the high-performance liquid chromatography market from the clinical laboratories segment is projected to observe a substantial CAGR during 2024-2032 owing to the crucial role in clinical diagnostics and research. HPLC is widely utilized in clinical laboratories for analyzing biomarkers, pharmaceutical compounds, vitamins, hormones, and metabolites with high sensitivity and precision. It also enables healthcare professionals to diagnose diseases, monitor therapeutic drug levels, and conduct pharmacokinetic studies effectively.

Asia Pacific high-performance liquid chromatography industry will witness a robust growth rate between 2024 and 2032. Rapid economic development in countries like China, India, and Japan is spurring investments in pharmaceutical R&D activities, fueling the demand for advanced analytical technologies. These countries are also increasingly focusing on drug discovery, quality control, and regulatory compliance in pharmaceutical manufacturing, stimulating regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 High accuracy and precision in analytical results
  - 3.2.1.2 Advancements in HPLC technologies
  - 3.2.1.3 Growing importance of HPLC tests in drug approvals
  - 3.2.1.4 Rise in R&D spending
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Lack of skilled professionals
  - 3.2.2.2 High cost of HPLC systems
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Instruments
- 5.2.1 HPLC systems
- 5.2.2 Pumps
- 5.2.3 Detectors
- 5.2.4 Other instruments
5.3 Consumables & accessories
- 5.3.1 Columns
  - 5.3.1.1 Reverse-phase HPLC columns
  - 5.3.1.2 Normal-phase HPLC Columns
  - 5.3.1.3 Ion exchange HPLC columns
  - 5.3.1.4 Other HPLC columns
- 5.3.2 Filters
- 5.3.3 Vials
- 5.3.4 Tubes
- 5.3.5 Other consumables & accessories

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Clinical research applications
6.3 Diagnostic applications
6.4 Forensic applications
6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Pharmaceutical & biotechnology companies
7.3 Clinical laboratories
7.4 Academic & research institutions
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa